<?xml version=“1.0” encoding=“UTF-8”?> <!DOCTYPE book-part PUBLIC “-//NLM//DTD BITS Book Interchange DTD with OASIS and XHTML Tables v2.0 20151225//EN”

"../BITS-book-oasis2.dtd">

<!– SYSTEM: Book Interchange Tag Suite –> <!– Updated May 2013 for testing –>

<book-part

book-part-type="introduction"
indexed="no"
seq="1"
xmlns:mml="http://www.w3.org/1998/Math/MathML"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:ali="http://www.niso.org/schemas/ali/1.0/" >

<book-part-meta> <book-part-id>Chapter-swsw-1</book-part-id>

<subj-group> <subject>Large Poodles</subject> </subj-group>

<title-group> <label>Chapter 1.</label> <title>BITS Book Chapter for DTD Testing</title> <subtitle>(Still a very small one for parsing)</subtitle> <alt-title>Bits chapter the first alternate title</alt-title> </title-group>

<contrib-group> <contrib id=“pt1-Prime-jjb” rid=“pt1-aff-1”> <name-alternatives> <name><surname>Jones</surname> <given-names>John Browning</given-names> <prefix>The Honorable</prefix><suffix>III</suffix> </name> <name specific-use=“Indexing”><surname>Jones</surname> <given-names>JBB</given-names> </name> <name name-style=“eastern” xml:lang=“ja-Jpan” specific-use=“Honorary”> <surname>flower-characters here</surname> <given-names>flower-characters here</given-names> </name> </name-alternatives> </contrib> <contrib> <name><surname>Jones</surname> <given-names>John Browning</given-names> <prefix>The Honorable</prefix><suffix>III</suffix> </name> </contrib> <aff-alternatives id=“pt1-aff-1” > <aff><institution xmlns:xlink=“www.w3.org/1999/xlink” xCounty“>type=”simple“>County Jail</institution> down Aberdeen way </aff> <aff> <institution xmlns:xlink=”www.w3.org/1999/xlink“ xMontgomery”>type=“simple”>Montgomery County Jail</institution> <uri xmlns:xlink=“www.w3.org/1999/xlink” xtype=“simple

xlink:href="http://www.archiemcphee.com">Archie McPhee</uri>

</aff> </aff-alternatives> </contrib-group>

<author-notes> <p>All is well, dear child!</p> </author-notes> <pub-date><year>2012</year></pub-date> <issn>000-222-444</issn> <isbn>xxx-1</isbn> <isbn>1-234 567890-123</isbn> <publisher> <publisher-name>Mulberry Technologies, Inc.</publisher-name> </publisher>

<pub-history> <date date-type=“manuscript-received”> <day>29</day> <month>01</month> <year>1999</year></date> <event> <event-desc>43rd printing special gold bindings edition</event-desc> <date iso-8601-date=“20120401”> <day>April Fool's Day</day> <month>04</month> <year>2012</year></date> <notes><p>Published as a giveaway for our 16th birthday party</p> </notes> </event> </pub-history>

<permissions> <copyright-statement>Copyright &#x00A9; 2012, Mulberry Technologies, Inc.</copyright-statement> <copyright-year content-type=“domestic”>2012</copyright-year> <copyright-holder>Mulberry Technologies, Inc.</copyright-holder> </permissions>

<abstract><p>All the good stuff</p> <sec> <title>Introduction</title> <p>And not for something completely different</p> </sec> <sec> <title>Discussion</title> <p>Or maybe not</p> </sec> <sec> <title>Conclusion</title> <p>All&rsquor;s well that ends well.</p> </sec> </abstract>

<kwd-group kwd-group-type=“author”> <kwd>DNA analysis</kwd> <kwd>gene expression</kwd>

<kwd>parallel cloning</kwd> <kwd>fluid microarray</kwd> </kwd-group>

<funding-group> <award-group id=“pt1-nih-509”> <funding-source country=“US”>NIH</funding-source> <award-id>NIH GM61374</award-id> <principal-award-recipient>Stanford</principal-award-recipient> </award-group> </funding-group> <funding-group> <award-group id=“pt1-nsf-510”> <funding-source country=“US”>NSF</funding-source> <award-id>NSF DBI-0317510</award-id> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> <award-group id=“pt1-arda-511” award-type=“contract”> <funding-source country=“US”>ARDA ACQUAINT</funding-source> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> <award-group id=“pt1-geneentech-512” award-type=“gift”> <funding-source country=“US”>Genentech Corp.</funding-source> <principal-award-recipient>Berkeley</principal-award-recipient> </award-group> </funding-group>

<counts> <book-fig-count count=“5”/> <book-table-count count=“3”/> <book-equation-count count=“10”/> <book-ref-count count=“26”/> <book-page-count count=“6”/> <book-word-count count=“2847”/> </counts>

<notes> <p>Always more to say</p> </notes>

</book-part-meta>

<body> <p>This following is an XHTML table, inside a Table Wrapper %lt;table-wrap&gt; wrapper, or prehaps a lettuce leaf, inside an enigma.</p> <p>Multiple paragrpahs are almost always a good idea to test <list list-type=“bullet”> <list-item><p>robustness, and</p></list-item> <list-item><p>fortitude.</p></list-item> </list></p> <p>The last paragraph had a bulleted list embedded within it, imagine that! How clever of it.</p>

<!– =============== An HTML Table =========== –> <table-wrap id=“pt1-table-wrap-XHTML” position=“anchor”> <label>Table 1</label> <caption><title>A Titled XHTML Table</title> <p>Additional caption &rsquo;material, which may spread to one or more paragraphs</p> </caption> <table> <tbody> <tr> <td>A cell!</td> <td>Another</td> <td>Still a third&gt;</td> </tr> <tr> <td>2 A cell!</td> <td>An xref: <xref ref-type=“statement” rid=“pt1-statement16”>See the statement</xref></td> <td>2 Still a third&gt;</td> </tr> </tbody> </table> </table-wrap> <!– =============== A Display Formula ======= –> <disp-formula> <tex-math id=“pt1-M1”>{minimal} usepackage{wasysym} usepackage[substack]{amsmath} usepackage{amsfonts} usepackage{amssymb} usepackage{amsbsy} usepackage[mathscr]{eucal} usepackage{mathrsfs} DeclareFontFamily{T1}{linotext}{} DeclareFontShape{T1}{linotext}{m}{n} { &#x003C;-&#x003E; linotext }{} DeclareSymbolFont{linotext}{T1}{linotext}{m}{n} DeclareSymbolFontAlphabet{mathLINOTEXT}{linotext} begin{document} $$ {mathrm{Acc/Acc:hspace{.5em}}}frac{{mathit{ade2-202}}}{{mathit{ADE2}}}\ hspace{.5em}frac{{mathit{ura3-59}}}{{mathit{ura3-59}}}hspace{.5em}frac{{\ mathit{ADE1}}}{{mathit{adel-201}}}hspace{.5em}frac{{mathit{ter1-Acc}}}{{\ mathit{ter1-Acc}}}hspace{.5em}frac{{mathit{MATa}}}{{mathit{MAT{alpha}}}} $$ end{document}]]> </tex-math> </disp-formula> <!– =============== A Section ======= –> <sec> <title>An OASIS Table for testing. Uses a nameswpace with prefrix “oasis”</title> <table-wrap id=“pt1-table-wrap-OASIS” position=“anchor”> <label>Table 1</label> <caption><title>An OASIS Table</title> <p>Additional caption material</p> </caption> <oasis:table

xmlns:oasis="http://www.niso.org/standards/z39-96/ns/oasis-exchange/table" >

<oasis:tgroup cols=“3”> <oasis:colspec colnum=“1” colname=“col1” colwidth=“2*” colsep=“1” rowsep=“1” align=“left”/> <oasis:colspec colnum=“2” colname=“col2” colwidth=“4*” colsep=“1” rowsep=“1” align=“left”/> <oasis:colspec colnum=“3” colname=“col3” colwidth=“*” colsep=“1” rowsep=“1” align=“right”/> <oasis:tbody> <oasis:row> <oasis:entry>A cell!</oasis:entry> <oasis:entry>Another</oasis:entry> <oasis:entry>Still a third&gt;</oasis:entry> </oasis:row> <oasis:row> <oasis:entry>A cell! <bold>the very first cell</bold></oasis:entry> <oasis:entry>Another cell with a <list list-type=“ordered”> <list-item><p>List item the first</p></list-item> <list-item><p>List item the second</p></list-item> <list-item><p>List item the third</p></list-item> </list></oasis:entry> <oasis:entry>Still a third&gt;</oasis:entry> </oasis:row> <oasis:row> <oasis:entry>2 A cell!</oasis:entry> <oasis:entry namest=“col2” nameend=“col3”>An xref: <xref ref-type=“statement” rid=“pt1-statement16”>See the statement</xref></oasis:entry> <oasis:entry>2 Still a third&gt;</oasis:entry> </oasis:row> </oasis:tbody> </oasis:tgroup> </oasis:table> </table-wrap> <p>Blah bljaissnmr0w s[8wy 89r wpeu.</p> </sec> <sec sec-type=“methods”> <title>There be statements here.</title> <statement id=“pt1-statement11”> <p>The IDREFs need to point to something</p> </statement> <statement id=“pt1-statement15”> <p>No Matter How Wise You Get, Wet Birds Don't Fly at Night</p> </statement> <statement id=“pt1-statement16”> <p>Post Hoc Propter Ergo Hoc</p> <p>EM4 cells, stably transfected with Flag-HA-DAT, Myc-His-DAT, or both, were reacted with cross-linker and solubilized in Triton X-100 as above. There is no reason to have this formula,<inline-formula> <mml:math><mml:semantics><mml:mrow><mml:msub><mml:mi>Q</mml:mi> <mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:mo>= </mml:mo><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow> <mml:mfrac><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>2</mml:mn></mml:msub> </mml:mrow><mml:mrow><mml:msub><mml:mi>M</mml:mi><mml:mn>1</mml:mn> </mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow> </mml:mrow><mml:mrow><mml:mn>10</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>T </mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi> T</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:msup></mml:mrow> <mml:annotation>Required: content unknown</mml:annotation> </mml:semantics></mml:math></inline-formula> here. Five microliters of anti-Myc 9E10 (Santa Cruz Biotechnology) was added to 1.0 ml of Triton X-100 extracts, and the mixture was incubated for 1 h at 4&#x00B0;C. Twenty microliters of rec-protein G Sepharose (Zymed) was added, and the mixture was incubated for 1 h at 4&#x00B0;C, washed three times in 0.5 ml of lysis buffer, and eluted in 45 &#x03BC;l of 2&#x00D7; Laemmli sample buffer without reducing agent.</p>

</statement> </sec> <sec sec-type=“quiz”> <question-wrap id=“Qw1”> <question question-response-type=“multiple-choice” id=“Q1”> <label>1</label> <p>The diagnosis of vasculitis rests upon which of the following?</p> <option id=“Q1-A” correct=“no” content-type=“multiple-choice”> <label>A</label> <p>A positive ANCA, PR3, or MPO antibody</p> </option> <option id=“Q1-B” correct=“no” content-type=“multiple-choice”> <label>B</label> <p>The presence of pulmonary nodules, cavities, and/or infiltrates</p> </option> <option id=“Q1-C” correct=“no” content-type=“multiple-choice”> <label>C</label> <p>The presence of glomerulonephritis</p> </option> <option id=“Q1-D” correct=“yes” content-type=“multiple-choice”> <label>D</label> <p>The clinician integrating clinical, laboratory, radiographic, and pathologic data and making a determination that the preponderance of the evidence collectively supports a diagnosis of vasculitis</p> </option> <option id=“Q1-E” correct=“no” content-type=“multiple-choice”> <label>E</label> <p>Fulfilling the correct number of elements required by specific published vasculitis classification criteria</p> </option> </question> </question-wrap>

<question-wrap id=“Qw2”> <question question-response-type=“multiple-choice” id=“Q2”> <label>2</label> <p>The diagnosis of vasculitis rests upon which of the following?</p> <option id=“Q2-A” correct=“no” content-type=“multiple-choice”> <label>A</label> <p>A positive ANCA, PR3, or MPO antibody</p> </option> <option id=“Q2-B” correct=“no” content-type=“multiple-choice”> <label>B</label> <p>The presence of pulmonary nodules, cavities, and/or infiltrates</p> </option> <option id=“Q2-C” correct=“no” content-type=“multiple-choice”> <label>C</label> <p>The presence of glomerulonephritis</p> </option> <option id=“Q2-D” correct=“yes” content-type=“multiple-choice”> <label>D</label> <p>The clinician integrating clinical, laboratory, radiographic, and pathologic data and making a determination that the preponderance of the evidence collectively supports a diagnosis of vasculitis</p> </option> <option id=“Q2-E” correct=“no” content-type=“multiple-choice”> <label>E</label> <p>Fulfilling the correct number of elements required by specific published vasculitis classification criteria</p> </option> </question> </question-wrap>

<question-wrap id=“Qw3”> <question question-response-type=“multiple-choice” id=“Q3”> <label>3</label> <p>The diagnosis of vasculitis rests upon which of the following?</p> <option id=“Q3-A” correct=“no” content-type=“multiple-choice”> <label>A</label> <p>A positive ANCA, PR3, or MPO antibody</p> </option> <option id=“Q3-B” correct=“no” content-type=“multiple-choice”> <label>B</label> <p>The presence of pulmonary nodules, cavities, and/or infiltrates</p> </option> <option id=“Q3-C” correct=“no” content-type=“multiple-choice”> <label>C</label> <p>The presence of glomerulonephritis</p> </option> <option id=“Q3-D” correct=“yes” content-type=“multiple-choice”> <label>D</label> <p>The clinician integrating clinical, laboratory, radiographic, and pathologic data and making a determination that the preponderance of the evidence collectively supports a diagnosis of vasculitis</p> </option> <option id=“Q3-E” correct=“no” content-type=“multiple-choice”> <label>E</label> <p>Fulfilling the correct number of elements required by specific published vasculitis classification criteria</p> </option> </question> </question-wrap>

</sec>

</body> </book-part>